OPDP reprimands Merz over Instagram ad for Botox competitor Xeomin
Regulatory NewsMichael Mezher
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesEnforcementUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsMichael MezherAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesEnforcementUnited StatesUS Food and Drug Administration (FDA)